[1]黄 芳,张 梦.益气宣肺汤联合穴位贴敷治疗老年慢性支气管炎急性发作临床研究[J].陕西中医,2021,(6):716-720.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.009]
　HUANG Fang,ZHANG Meng.Clinical study on Yiqi Xuanfei decoction combined with acupoint application in treatment of acute attack of chronic bronchitis in the elderly[J].,2021,(6):716-720.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.009]
点击复制

益气宣肺汤联合穴位贴敷治疗老年慢性支气管炎急性发作临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年6期
页码:
716-720
栏目:
临床研究
出版日期:
2021-06-05

文章信息/Info

Title:
Clinical study on Yiqi Xuanfei decoction combined with acupoint application in treatment of acute attack of chronic bronchitis in the elderly
作者:
黄 芳; 张 梦
(武汉市中心医院,湖北 武汉 430014)
Author(s):
HUANG Fang; ZHANG Meng
(The Central Hospital of Wuhan,Wuhan 430014,China)
关键词:
慢性支气管炎急性发作;  益气宣肺汤;  穴位贴敷;  血气指标;  炎症因子;  免疫功能
Keywords:
Acute attack of chronic bronchitis;  Yiqi Xuanfei decoction;  Acupoint application;  Blood gas index;  Inflammatory factor;  Immune Function
分类号:
R 562.2
DOI:
DOI:10.3969/j.issn.1000-7369.2020.06.009
文献标志码:
A
摘要:
目的:观察益气宣肺汤联合穴位贴敷治疗老年慢性支气管炎急性发作(AECB)的疗效。方法:128例老年AECB患者随机分为两组,对照组64例采用西医治疗,观察组64例在对照组基础上予益气宣肺汤和穴位贴敷治疗。对比两组中医症状积分、血气指标、炎症因子指标以及免疫功能,并观察两组疗效和安全性。结果:观察组治疗后中医症状积分低于对照组(P<0.05)。两组治疗后患者PaO2、SpO2指标升高、PaCO2指标下降,且观察组PaO2、SpO2水平高于对照组,PaCO2低于对照组,差异有统计学意义(均P<0.05)。两组患者治疗后hs-CRP、IL-1β、IL-8、PCT和sTREM-1指标下降,IL-10升高,且两组比较差异有统计学意义(均P<0.05)。两组患者治疗后的IgG、IgA、IgM指标升高,且观察组高于对照组(均P<0.05)。观察组总有效率92.19%高于对照组的78.13%(P<0.05)。观察组不良反应发生率7.81%、对照组为6.25%,组间比较差异无统计学意义(P>0.05)。结论:益气宣肺汤联合穴位贴敷治疗老年AECB能改善患者临床症状及血气指标,降低炎症反应,提高免疫功能,疗效较好。
Abstract:
Objective:To explore the efficacy of Yiqi Xuanfei decoction combined with acupoint application in the treatment of acute exacerbation of chronic bronchitis(AECB)in the elderly.Methods:128 elderly AECB patients were randomly divided into two groups.64 cases in the control group were treated with western medicine.64 cases in the observation group were treated with Yiqi Xuanfei decoction and acupoint application base on the treatment of the control group.TCM syndrome scores,blood gas indicators,inflammatory factors indicators and immune function were compared between the two groups.The efficacy and safety of the two groups were observed.Results:The TCM symptom score of the observation group was lower than that of the control group(P<0.05).After treatment,PaO2 and SpO2 in the two groups increased,while PaO2 decreased.The levels of PaO2 and SpO2 in the observation group were higher than those in the control group,while the levels of PaCO2 was lower than that in the control group,with statistical significance(all P<0.05).After treatment,hs-CRP,IL-1β,IL-8,PCT and sTREM-1 in the two groups were decreased,while IL-10 increased,and the differences between the two groups were statistically significant(all P<0.05).After treatment,the IgG,IgA and IgM in the two groups were increased,and the observation group were higher than those in the control group(all P<0.05).The total effective rate of the observation group was 92.19% higher than the control group 78.13%(P<0.05).The adverse reaction rate of the observation group was 7.81%,and that of the control group was 6.25%.There was no significant difference between the two groups(P>0.05).Conclusion:Yiqi Xuanfei decoction combined with acupoint application in the treatment of elderly AECB can improve symptoms and blood gas indicators,reduce inflammation,improve immune function,and have better clinical effects.

参考文献/References:

[1] 杨艳荣,李 璇.陕西宝鸡地区老年慢性支气管炎患者呼吸道感染病原体检测结果研究[J].陕西医学杂志,2018,47(5):668-670.
[2] 张 芳.温肺化痰汤加减治疗慢性喘息型支气管炎急性发作期临床观察[J].陕西中医,2017,38(5):590-592.
[3] 钟南山.呼吸内科学[M].北京:人民卫生出版社,2008:51.
[4] 冯维斌,刘伟胜.呼吸科专病中医临床诊治[M].北京:人民卫生出版社,2000:181.
[5] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:104.
[6] 刘又宁.呼吸内科学高级教程[M].北京:人民军医出版社,2013:63.
[7] Tang H,Fang Z,Saborio GP,et al.Efficacy and safety of om-85 in patients with chronic bronchitis and/or chronic obstructive pulmonary disease[J].Lung,2015,193(4):513-519.
[8] 王 静,崔 霞.基于网络药理学探讨黄芪治疗反复呼吸道感染的作用机制[J].中医药导报,2020,358(12):112-118.
[9] 宋 叶,林 东,梅全喜,等.太子参化学成分及药理作用研究进展[J].中国药师,2019,22(8):1506-1510.
[10] 温亚娟,项丽玲,苗明三.薄荷的现代应用研究[J].中医学报,2016,31(12):1963-1965.
[11] 雷奇林,黄雅兰,钟 茜,等.基于网络药理学的黄芩抗炎作用机制研究[J].中草药,2018,49(15):3523-3530.
[12] 朱晓丹,安 超,李泉旺,等.中药浙贝母药用源流及发展概况[J].世界中医药,2017,12(1):211-216,221.
[13] 孟 泳.益气宣肺汤联合雾化吸入治疗老年慢性支气管炎的疗效分析[J].陕西中医,2018,39(2):244-246.
[14] 左 力,孟 阔.中药穴位贴敷理论在老年慢性支气管炎治疗中应用效果观察[J].临床军医杂志,2016,44(6):617-619,623.
[15] 平秀琴,杨 红,吴晓萍,等.清金化痰汤联合异丙托溴铵对痰热壅肺型慢性支气管炎免疫功能及血气分析指标的影响[J].中华中医药学刊,2020,38(11):67-70.
[16] 王芳杰,崔虎啸,史广超.三子止咳胶囊联合二羟丙茶碱治疗慢性支气管炎急性发作的临床研究[J].现代药物与临床,2018,33(12):3212-3215.
[17] 庄鹏晖,刘亮亮,郑国玺,等.支气管哮喘患者血清肿瘤坏死因子-α、白细胞介素-8和嗜酸性粒细胞阳离子蛋白水平变化及意义[J].陕西医学杂志,2020,49(12):1597-1599,1603.
[18] 王俊姬,何 平,薛泽恩,等.血清脑源性神经营养因子、白细胞介素-8、肿瘤坏死因子-α、超氧化物歧化酶水平对新生儿缺氧缺血性脑病严重程度及预后的评估价值[J].陕西医学杂志,2020,49(11):1465-1468,1522.
[19] 刘文东,李 红,王彩霞,等.过敏性紫癜患儿血清细胞因子的检测及意义[J].中国小儿急救医学,2009,16(1):65-66.
[20] 刘杜姣,王鹿杰,薛庆亮,等.血清可溶性髓样细胞触发受体-1水平在下呼吸道感染诊断中的意义[J].中国感染与化疗杂志,2013,13(1):76-78.

相似文献/References:

[1]苏 平,曹利平,蔡绪明,等.益气宣肺汤治疗老年功能性便秘气虚证临床研究[J].陕西中医,2021,(9):1257.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.028]
　SU Ping,CAO Liping,CAI Xuming,et al.Clinical study on Yiqi Xuanfei decoction in treating functional constipation with Qixu syndrome in old age[J].,2021,(6):1257.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.028]
[2]蒙 绮,周 进.益气宣肺汤治疗老年哮喘疗效及对患者炎症因子和免疫功能的影响[J].陕西中医,2024,(10):1345.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.010]
　MENG Qi,ZHOU Jin.The therapeutic effect of Yiqi Xuanfei decoction on elderly asthmatic patients and its role in regulating inflammatory factors and immune function[J].,2024,(6):1345.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.010]

备注/Memo

备注/Memo:
基金项目:湖北省卫生和计划生育委员会科研项目(WZ18E05)
更新日期/Last Update: 2021-06-09